Trial Summary
What is the purpose of this trial?
The study team will conduct a cluster randomized control trial in 10 NYU primary care practices to assess the effectiveness and implementation of the multicomponent intervention on medication adherence and blood pressure control for patients who are non-adherent to antihypertensive medications.
Eligibility Criteria
This trial is for adults over 18 with high blood pressure, diagnosed as having a reading of at least 140/90 or already on antihypertensive medication. They must have visited an NYULH outpatient clinic between June 2022 and December 2025. Healthcare workers involved include physicians, medical assistants, nurses at NYULH ambulatory locations.Inclusion Criteria
I am a healthcare professional at NYULH seeing adult patients.
I am over 18 and have high blood pressure or am on medication for it.
Exclusion Criteria
No specific exclusion criteria for patients in chart review
I do not wish to be observed without treatment.
Treatment Details
Interventions
- Electronic Health Record (EHR) Enabled Teamlets (Behavioral Intervention)
Trial OverviewThe study tests if using 'teamlets'—small healthcare teams guided by Electronic Health Records (EHR)—helps patients stick to their blood pressure medications better and control their hypertension more effectively in primary care settings across up to 22 NYU clinics.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Group II: Usual Care GroupActive Control1 Intervention
Usual Care Clinical Decision Support (CDS) Tools
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
NYU Langone HealthNew York, NY
Loading ...
Who Is Running the Clinical Trial?
NYU Langone HealthLead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)Collaborator